Does Dr
Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M
Alzheimer's patients saw their cognitive function improve by 29% (ADAS-Cog scores) after 84 days of CMA treatment
Reasons for treatment discontinuation include, but are not limited to, gastrointestinal adverse effects, less-than-desired efficacy, high cost, and fear about uncommon or rare adverse effects
Semaglutide not only consistently reduces energy intake (Blundell et al., 2017) but also achieves substantial weight loss, up to approximately 15% in individuals who are overweight or obese (Wilding et al., 2021)
Such widespread usage has led to a severe and prolonged international shortage of these drugs 13,14 , with consequent lack of access to treatment for patients with diabetes 15 and the urgent need to issue guidelines for alternative treatments 16